Clinical outcomes with rapid detection of methicillin-resistant and methicillin-susceptible staphylococcus aureus isolates from routine blood cultures

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4126-4129

  Nicolsen, Nicole C ^a   LeCroy, Nicholas ^a   Alby, Kevin ^a   Laux, Jeffrey ^b   Lin, Feng Chang ^b   Daniels, Lindsay ^a   Weber, David J ^c   Miller, Melissa B ^a,c  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b North Carolina Translational and Clinical Sciences Institute   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; COLISTIN; METICILLIN; NALIDIXIC ACID; VANCOMYCIN;

ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLOOD CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LABORATORY DEVICE; LENGTH OF STAY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS INFECTION; SURVIVAL;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; CULTURE MEDIA; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84889857139     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01667-13     Document Type: Article

References (9)

1. Biedenbach DJ, Moet GJ, Jones RN. 2004. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn. Microbiol. Infect. Dis. 50:59-69.
2. Styers D, Sheehan DJ, Hogan P, Sahm DF. 2006. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Microbiol. Antimicrob. 5:2-11.
3. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. 2012. Predictors of mortality in Staphylococcus aureus bacteremia. Clin. Microbiol. Rev. 25:362-386.
4. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. 2002. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch. Intern. Med. 162:2229-2235.
5. Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN. 2011. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect. Dis. 11:279-285.
6. Gould IM. 2013. Treatment of bacteraemia: methicillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA). Int. J. Antimicrob. Agents 425:S17-S21.
7. Chihara S, Hayden MK, Minogue-Corbett E, Singh K. 2009. Shortened time to identify Staphylococcus species from blood cultures and methicillin resistance testing using CHROMagar. Int. J. Microbiol. 2009:636502. doi: 10.1155/2009/636502.
8. Geiger K, Brown J. 2013. Rapid testing for methicillin-resistant Staphylococcus aureus: implications for antimicrobial stewardship. Am. J. Health Syst. Pharm. 70:335-342.
9. Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. 2012. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am. J. Health Syst. Pharm. 69: 1910-1914.